SecBot SecBot
8-K ·Filed Oct 15, 2026

OLMA

Olema Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 12h ago SEC0001193125-26-423002
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any subsequent director departures or changes in board composition that could signal governance shifts. No immediate trading catalyst from this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+5d
OLMA ▼ -2.58% at T+5d
NEUTRAL call -2.58% · α vs SPY -2.15% · entry $6.58 → $6.41
Next anchor: T+20d in 15d
Entry = T+0 close
Oct 15, 2026
via day close
T+1d
+8.05%
call +8.05% · α +7.63%
$7.11
settled 12d ago
T+5d
-2.58%
call -2.58% · α -2.15%
$6.41
settled 6d ago
T+20d
Pending
in 15d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Olema Pharmaceuticals disclosed the resignation of board member Dr. Gorjan Hrustanovic, effective October 14, 2026, who also stepped down from the Compensation and Science & Technology Committees. The resignation was explicitly stated as not due to any disagreement with the company. Dr. Prakash Raman was appointed to both committees effective October 15, 2026. This is a routine board committee reshuffle with no material financial or operational impact.

Key Facts

  • Dr. Gorjan Hrustanovic resigned from the Board of Directors effective October 14, 2026.
  • Resignation was not the result of any disagreement with the company's operations, policies, or practices.
  • Dr. Prakash Raman appointed to the Compensation Committee and Science and Technology Committee effective October 15, 2026.

Financial Impact

No financial impact — routine board committee changes with no compensation or operational changes disclosed.

Risk Factors

  • No material risks identified from this filing.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-423002
Document: 0001193125-26-423002-index-headers.html0001193125-26-423002
Document: 0001193125-26-423002-index.html0001193125-26-423002
Document: 0001193125-26-423002.txt0001193125-26-423002
16 reports for OLMA
Performance horizon
25% Hit rate @ T+20 1 of 4 directional calls Went positive at some point 1 of 4 best @ T+1▲ +12.65%Aug 9, 2026
Filters
Rows
Reports for OLMA, sortable and filterable
TypeNow
Oct 16, 2026
11d ago
SC 13D/A
NEUTRAL ★ 2/10
$7.11awaiting T+20awaiting T+20$7.04 (−0.98%)
Oct 15, 2026
12d ago
8-K
NEUTRAL ★ 2/10
$6.58awaiting T+20awaiting T+20$7.04 (+6.99%)
Oct 2, 2026
25d ago
Press Release
NEUTRAL ★ 2/10
$8.25awaiting T+20awaiting T+20$7.04 (−14.67%)
Aug 10, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$10.43 $10.36▼ −0.67%▲ +0.39%$7.04 (−32.50%)
Aug 10, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$10.43 $10.36▼ −0.67%▲ +0.39%$7.04 (−32.50%)
Aug 9, 2026
11w ago
Institutional Cluster
BEARISH ★ 6/10
$11.94 $10.99▲ +8.00%▲ +7.08%$7.04 (+41.04%)
May 26, 2026
22w ago
8-K
BULLISH ★ 6/10
$13.55 $11.46▼ −15.42%▼ −13.48%$7.04 (−48.04%)
May 26, 2026
22w ago
Press Release
NEUTRAL ★ 4/10
$13.55 $11.46▼ −15.42%▼ −13.48%$7.04 (−48.04%)
May 21, 2026
22w ago
8-K
BULLISH ★ 6/10
$13.68 $10.19▼ −25.51%▼ −24.10%$7.04 (−48.54%)
May 21, 2026
22w ago
Press Release
BULLISH ★ 6/10
$13.68 $10.19▼ −25.51%▼ −24.10%$7.04 (−48.54%)
Showing 10 of 16

US Market Status

Market Closed · Opens in 4h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 15, 2026